Inogen (INGN) Gross Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -724.00 |
| Dec 31, 2025 | -292.00 |
| Sep 30, 2025 | 31.00 |
| Jun 30, 2025 | -511.00 |
| Mar 31, 2025 | -194.00 |
| Dec 31, 2024 | 233.00 |
| Sep 30, 2024 | -66.00 |
| Jun 30, 2024 | -154.00 |
| Mar 31, 2024 | -518.00 |
| Dec 31, 2023 | -1,325.00 |
| Sep 30, 2023 | -1,101.00 |
| Jun 30, 2023 | -914.00 |
| Mar 31, 2023 | -514.00 |
| Dec 31, 2022 | -1,476.00 |
| Sep 30, 2022 | -744.00 |
| Jun 30, 2022 | -448.00 |
| Mar 31, 2022 | -549.00 |
| Dec 31, 2021 | 196.00 |
| Sep 30, 2021 | 1,272.00 |
| Jun 30, 2021 | 770.00 |
| Mar 31, 2021 | 223.00 |
| Dec 31, 2020 | -350.00 |
| Sep 30, 2020 | -311.00 |
| Jun 30, 2020 | 262.00 |
| Mar 31, 2020 | -133.00 |
| Dec 31, 2019 | -446.00 |
| Sep 30, 2019 | -263.00 |
| Jun 30, 2019 | -4.00 |
| Mar 31, 2019 | -128.00 |
| Dec 31, 2018 | -114.00 |
| Sep 30, 2018 | 247.00 |
| Jun 30, 2018 | -501.00 |
| Mar 31, 2018 | -382.00 |